Cellular Radiosensitivity of Soft Tissue Sarcoma.


Journal

Radiation research
ISSN: 1938-5404
Titre abrégé: Radiat Res
Pays: United States
ID NLM: 0401245

Informations de publication

Date de publication:
01 07 2021
Historique:
received: 24 09 2020
accepted: 19 03 2021
pubmed: 30 4 2021
medline: 14 10 2021
entrez: 29 4 2021
Statut: ppublish

Résumé

Currently, all soft tissue sarcomas (STS) are irradiated by the same regimen, disregarding possible subtype-specific radiosensitivities. To gain further insight, cellular radiosensitivity was investigated in a panel of sarcoma cell lines. Fourteen sarcoma cell lines, derived from synovial sarcoma, leiomyosarcoma, fibrosarcoma and liposarcoma origin, were submitted to clonogenic survival assays. Cells were irradiated with single doses from 1-8 Gy and surviving fraction (SF) was calculated from the resulting response data. Alpha/beta (α/β) ratios were inferred from radiation-response curves using the linear-quadratic (LQ)-model. Cellular radiosensitivities varied largely in this panel, indicating a considerable degree of heterogeneity. Surviving fraction after 2 Gy (SF2) ranged from 0.27 to 0.76 with evidence of a particular radiosensitive phenotype in only few cell lines. D37% on the mean data was 3.4 Gy and the median SF2 was 0.52. The median α/β was 4.9 Gy and in six cell lines the α/β was below 4 Gy. A fairly homogeneous radiation response was observed in myxoid liposarcoma cell lines with SF2 between 0.64 and 0.67. Further comparing sarcomas of different origin, synovial sarcomas, as a group, showed the lowest SF2 values (mean 0.35) and was significantly more radiosensitive than myxoid liposarcomas and leiomyosarcomas (P = 0.0084 and 0.024, respectively). This study demonstrates a broad spectrum of radiosensitivities across STS cell lines and reveals subtype-specific radiation responses. The particular cellular radiosensitivity of synovial sarcoma cells supports consideration of the different sarcoma entities in clinical studies that aim to optimize sarcoma radiotherapy.

Identifiants

pubmed: 33914890
pii: 464693
doi: 10.1667/RADE-20-00226.1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-30

Informations de copyright

©2021 by Radiation Research Society. All rights of reproduction in any form reserved.

Auteurs

R L Haas (RL)

Department of Radiotherapy, The Netherlands Cancer Insititute, Amsterdam, The Netherlands.

B G J Floot (BGJ)

Department of Surgical Oncology, The Netherlands Cancer Insititute, Amsterdam, The Netherlands.

A N Scholten (AN)

Department of Radiotherapy, The Netherlands Cancer Insititute, Amsterdam, The Netherlands.

W T A van der Graaf (WTA)

Division of Cell Biology, The Netherlands Cancer Insititute, Amsterdam, The Netherlands.

W van Houdt (W)

Department of Medical Oncology, The Netherlands Cancer Insititute, Amsterdam, The Netherlands.

Y Schrage (Y)

Department of Medical Oncology, The Netherlands Cancer Insititute, Amsterdam, The Netherlands.

M van de Ven (M)

Preclinical Intervention Unit, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Insititute, Amsterdam, The Netherlands.

J V M G Bovée (JVMG)

Department of Pathology, Leiden University Medical Centre, Leiden, the Netherlands.

F van Coevorden (F)

Department of Medical Oncology, The Netherlands Cancer Insititute, Amsterdam, The Netherlands.

C Vens (C)

Department of Radiotherapy, The Netherlands Cancer Insititute, Amsterdam, The Netherlands.
Department of Surgical Oncology, The Netherlands Cancer Insititute, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH